CRP and congenital rubella syndrome: In a phase I trial of EGFRvIII-targeted CART cells given intravenously to patients with glioblastoma, symptoms including fever, hypotension, and elevated CRP and IL-6 were observed but attributed to localized intracranial CRS rather than systemic CRS (44).